HL7 Terminology (THO)
5.5.0 - Publication
This page is part of the HL7 Terminology (v5.5.0: Release) based on FHIR (HL7® FHIR® Standard) R4. The current version which supersedes this version is 7.0.0. For a full list of available versions, see the Directory of published versions
| Official URL: http://terminology.hl7.org/NamingSystem/NCPDPBrandGenericIndicator | Version: 1.0.1 | |||
| Active as of 2021-03-10 | Responsible: National Council for Prescription Drug Programs | Computable Name: NCPDPBrandGenericIndicator | ||
Denotes brand or generic drug dispensed.
| Defining URL | http://terminology.hl7.org/NamingSystem/NCPDPBrandGenericIndicator |
| Version | 1.0.1 |
| Name | NCPDPBrandGenericIndicator |
| Title | NCPDP Brand Generic Indicator |
| Status | active |
| Definition | Denotes brand or generic drug dispensed. |
| Publisher | National Council for Prescription Drug Programs |
| Type | Value | Preferred |
| URI | http://terminology.hl7.org/CodeSystem/NCPDPBrandGenericIndicator | true |
History
| Date | Action | Custodian | Author | Comment |
| 2020-11-17 | create | HTA | Jessica Bota | HTA approved entries for external code systems owned by NCPDP; implement UP-130. |